Sable Bio Secures £1.5 Million to Revolutionize Drug Safety Testing with AI
London-based biotech startup, Sable Bio, has successfully raised £1.5 million in a pre-seed funding round aimed at advancing its cutting-edge drug safety testing technology. London-based biotech startup, Sable Bio, has…